Brimonidine Tartrate Solution/ Drops
Product Images NDC 42571-419

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 42571-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-carta.jpg (Brimonidine Carta)

This text provides information about Brimonidine Tartrate Ophthalmic Solution, with details on its ingredients, usage instructions, dosages, storage recommendations, and warnings. It also includes the manufacturer's information and a warning not to touch the dropper tip to prevent contamination.*

FDA Label Image

Brimonidine-lbla.jpg (Brimonidine Lbla)

This is a description of Brimonidine Tartrate Ophthalmic Solution, an eye drop medication prescribed for topical ophthalmic use. It contains 0.2% Brimonidine Tartrate as the active ingredient and 0.005% Benzalkonium Chloride as a preservative. The usual dosage is one drop instilled three times daily in the affected eye(s), with approximately 8 hours between each dose. The medication should be stored between 15° to 25°C. It is important not to use the product if the "Tear-off ring" is broken or missing. The medication is manufactured by Micro Labs USA, Inc., in India.*

FDA Label Image

Brimonidine-str.jpg (Brimonidine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.